文献速递泌尿生殖腹部CT

CT上模拟肾囊肿的低衰减均匀型乳头状肾细胞癌的患病率

Prevalence of Low-Attenuation Homogeneous Papillary Renal Cell Carcinoma Mimicking Renal Cysts on CT.
PubMed 文献 · AJR Am J Roentgenol · 2018-09-21

该回顾性双中心研究分析了114例病理证实的乳头状肾细胞癌的多期CT,排除主观不均匀病例后,42例均匀型病灶各期CT衰减范围为:平扫14.7-50.7 HU,皮髓质期32.2-99.5 HU,门静脉期40.8-95.1 HU,肾实质期17.9-90.8 HU,排泄期18.0-73.0 HU;仅2例(1.8%)在门静脉期或肾实质期均匀且低于30 HU,3例(2.8%)平扫均匀且低于20 HU。结论认为乳头状肾细胞癌同时满足主观均匀且平扫低于20 HU、门静脉期或肾实质期低于30 HU的情况罕见。

要点

  • 乳头状肾细胞癌各期CT衰减范围:平扫14.7-50.7 HU,皮髓质期32.2-99.5 HU,门静脉期40.8-95.1 HU,肾实质期17.9-90.8 HU,排泄期18.0-73.0 HU。
  • 114例中仅2例(1.8%,95%CI 0.2-6.5%)在门静脉期或肾实质期均匀且低于30 HU,其中1例为实性低强化肿块、1例为均匀囊性肾细胞癌。
  • 107例有平扫期的病例中3例(2.8%,95%CI 0.6-8.8%)均匀且平扫低于20 HU。

核心结论

  • 乳头状肾细胞癌同时表现为主观均匀且平扫CT低于20 HU、门静脉期或肾实质期CT低于30 HU的情况罕见。

研究设计与样本

  • 回顾性研究,2007年1月1日至2017年1月1日于两家机构进行,纳入114例病理证实的乳头状肾细胞癌患者,行含与不含静脉对比剂的多期CT,由两组各两名腹部放射科医师独立阅片。

关键影像表现/征象

  • 平均病灶大小2.8 cm(范围1.2-11.0 cm)。
  • 42例均匀型乳头状肾细胞癌各期CT衰减范围:平扫14.7-50.7 HU,皮髓质期32.2-99.5 HU,门静脉期40.8-95.1 HU,肾实质期17.9-90.8 HU,排泄期18.0-73.0 HU。
  • 114例中2例(1.8%,95%CI 0.2-6.5%)在门静脉期或肾实质期均匀且低于30 HU,其中1例为实性低强化肿块,另1例为均匀囊性肾细胞癌。
  • 107例有平扫期的病例中3例(2.8%,95%CI 0.6-8.8%)均匀且平扫低于20 HU。

诊断标准与关键数值

  • 均匀型乳头状肾细胞癌平扫CT衰减范围14.7-50.7 HU。
  • 均匀型乳头状肾细胞癌门静脉期CT衰减范围40.8-95.1 HU、肾实质期17.9-90.8 HU。
  • 114例中2例(1.8%,95%CI 0.2-6.5%)在门静脉期或肾实质期均匀且低于30 HU。
  • 107例有平扫期的病例中3例(2.8%,95%CI 0.6-8.8%)均匀且平扫低于20 HU。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The objective of our study was to determine the attenuation range of homogeneous papillary renal cell carcinomas (RCCs) on contrast-enhanced CT.

MATERIALS AND METHODS: This retrospective study was performed at two institutions from January 1, 2007, to January 1, 2017. Multiphasic CT studies with and without IV contrast material of 114 patients with pathologically proven papillary RCCs were independently reviewed by two sets of two abdominal radiologists. Seventy-two cases were excluded because of subjective lesion heterogeneity, leaving 42 homogeneous RCCs. Three ROIs were placed on all lesions for all CT phases, and the mean attenuations were calculated.

RESULTS: Mean lesion size was 2.8 cm (range, 1.2-11.0 cm). The attenuation range for each CT phase was as follows: unenhanced, 14.7-50.7 HU; corticomedullary, 32.2-99.5 HU; portal venous, 40.8-95.1 HU; nephrographic, 17.9-90.8 HU; and excretory, 18.0-73.0 HU. Two of 114 (1.8%; 95% CI, 0.2-6.5%) RCCs were homogeneous and less than 30 HU on the portal venous or nephrographic phase. One of these RCCs was a solid hypoenhancing mass, and the other was a homogeneous cystic RCC. Of the cases with an unenhanced phase, three of 107 (2.8%; 95% CI, 0.6-8.8%) were both homogeneous and were less than 20 HU in attenuation.

CONCLUSION: Papillary RCCs are rarely both subjectively homogeneous and less than 20 HU at unenhanced CT and less than 30 HU at portal venous or nephrographic phase CT.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Corwin MT, Loehfelm TW, McGahan JP, et al. Prevalence of Low-Attenuation Homogeneous Papillary Renal Cell Carcinoma Mimicking Renal Cysts on CT. AJR Am J Roentgenol. 2018. PMID: 30240301. doi:10.2214/AJR.18.19744

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。